Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-009201
Filing Date
2023-03-22
Accepted
2023-03-22 16:30:07
Documents
87
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K scph-20221231.htm   iXBRL 10-K 3544215
2 EX-10.5 scph-ex10_5.htm EX-10 238321
3 EX-10.6 scph-ex10_6.htm EX-10 22891
4 EX-10.11 scph-ex10_11.htm EX-10 149284
5 EX-23.1 scph-ex23_1.htm EX-23 6741
6 EX-31.1 scph-ex31_1.htm EX-31 19560
7 EX-31.2 scph-ex31_2.htm EX-31 19539
8 EX-32.1 scph-ex32_1.htm EX-32 12928
9 EX-32.2 scph-ex32_2.htm EX-32 12160
  Complete submission text file 0000950170-23-009201.txt   12663391

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT scph-20221231.xsd EX-101.SCH 62680
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT scph-20221231_pre.xml EX-101.PRE 415636
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT scph-20221231_cal.xml EX-101.CAL 68165
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT scph-20221231_lab.xml EX-101.LAB 560657
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT scph-20221231_def.xml EX-101.DEF 214038
81 EXTRACTED XBRL INSTANCE DOCUMENT scph-20221231_htm.xml XML 2388839
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38293 | Film No.: 23753285
SIC: 2834 Pharmaceutical Preparations